Slingshot Biosciences, Inc. — Form D
Slingshot Biosciences, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-06. The offering totals $11.2M, of which $11.2M was reported sold. Industry: Other.
Offering
- Filed: 2023-02-06
- Form: D
- Accession: 0001867067-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $11.2M
- Amount sold: $11.2M
- Investors: 8
- Date of first sale: 2023-01-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-472755
Issuer
- Name: Slingshot Biosciences, Inc.
- CIK: 0001867067
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1250 45TH STREET, SUITE 330, EMERYVILLE, CA, 94608
- Phone: (510) 770-6806
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Adam J Wieschhaus | Director | Emeryville, CA |
| Nicolas J Barthelemy | Director | Emeryville, CA |
| Patrick J Weiss | Director | Emeryville, CA |
| Corey J Ritter | Director | Emeryville, CA |
| Andrew J Lee | Director | Emeryville, CA |
| Ronald J Silberman | Director | Emeryville, CA |
| Jeffrey Kim | Director | Emeryville, CA |
| Jeffrey Kim | Executive Officer | Emeryville, CA |
Other filings by this issuer (3)
More